3 Results Found

Advanced Search

Select all

Results per page

Select all

Case Report

985 Views

7 Pages

Secondary Hemophagocytic Lymphocytosis in Inflammatory Bowel Disease

Jacob Boccucci,
Ramalakshmi Thulluri,
Chandini Kannan,
Matthew Gold and
Vamsi Kota

Hematol. Rep.2025, 17(4), 33;https://doi.org/10.3390/hematolrep17040033

-

30 June 2025

Background and Clinical Significance: Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition that can go underdiagnosed due to overlapping features with severe infections. While the use of thiopurine in inflammatory bowel d...

Full Article

Case Report

1,670 Views

17 Pages

Lymphoid and Myeloid Proliferations After Chimeric Antigen Receptor (CAR) T-Cell Therapy: The Pathologist’s Perspective

Jiehao Zhou and
Katalin Kelemen

Int. J. Mol. Sci.2025, 26(17), 8388;https://doi.org/10.3390/ijms26178388

-

28 August 2025

Chimeric antigen receptor (CAR) T-cell infusion has led to improved outcomes in patients with B-lymphoblastic leukemia, B-cell lymphoma, and multiple myeloma. The spectrum of post-CAR T-cell hematolymphoid abnormalities is expanding, although they re...

Full Article

Case Report

761 Views

13 Pages

The Many Faces of Primary EBV Infection: A Case Series of Its Diverse Presentations

Sylvia Lörcher,
Christian Abegg,
Alexander Wepf,
Urs Karrer and
Michael Osthoff

J. Clin. Med.2025, 14(24), 8747;https://doi.org/10.3390/jcm14248747

-

10 December 2025

Epstein–Barr virus (EBV) is distributed worldwide and shows a seroprevalence of over 90% in adults, while seroprevalence in children varies depending on geographic and socioeconomic factors. Although primary EBV infection (pEBV) is often asympt...

Full Article